These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33622380)

  • 21. Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: A structured review.
    Alobaid AS; Hites M; Lipman J; Taccone FS; Roberts JA
    Int J Antimicrob Agents; 2016 Apr; 47(4):259-68. PubMed ID: 26988339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dosing of medications in morbidly obese patients in the intensive care unit setting.
    Erstad BL
    Intensive Care Med; 2004 Jan; 30(1):18-32. PubMed ID: 14625670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudy.
    Chi G; Gibson CM; Kalayci A; Cohen AT; Hernandez AF; Hull RD; Kahe F; Jafarizade M; Sharfaei S; Liu Y; Harrington RA; Goldhaber SZ
    Intensive Care Med; 2019 Apr; 45(4):477-487. PubMed ID: 30778649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacologic venous thromboembolism prophylaxis in obese trauma patients.
    Erstad BL; Barletta JF
    Am J Health Syst Pharm; 2023 Feb; 80(5):258-266. PubMed ID: 36445848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of anticoagulants for the treatment and prevention of venous thromboembolism in obese patients: implications for safety.
    Ihaddadene R; Carrier M
    Expert Opin Drug Saf; 2016 Jan; 15(1):65-74. PubMed ID: 26568174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of venous thromboembolism in critically ill medical patients: a Franco-Canadian cross-sectional study.
    Lacherade JC; Cook D; Heyland D; Chrusch C; Brochard L; Brun-Buisson C;
    J Crit Care; 2003 Dec; 18(4):228-37. PubMed ID: 14691896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of current evidence available for guiding optimal Enoxaparin prophylactic dosing strategies in obese patients-Actual Weight-based vs Fixed.
    He Z; Morrissey H; Ball P
    Crit Rev Oncol Hematol; 2017 May; 113():191-194. PubMed ID: 28427508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemical prophylaxis to prevent venous thromboembolism in morbid obesity: literature review and dosing recommendations.
    Vandiver JW; Ritz LI; Lalama JT
    J Thromb Thrombolysis; 2016 Apr; 41(3):475-81. PubMed ID: 25982217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of Commonly Used Medications in Children Receiving Continuous Renal Replacement Therapy: A Systematic Review of Current Literature.
    Dubinsky S; Watt K; Saleeb S; Ahmed B; Carter C; Yeung CHT; Edginton A
    Clin Pharmacokinet; 2022 Feb; 61(2):189-229. PubMed ID: 34846703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Prophylactic Heparin Dosage Strategies and Risk Factors for Venous Thromboembolism in the Critically Ill Patient.
    Reynolds PM; Van Matre ET; Wright GC; McQueen RB; Burnham EL; Ho PJM; Moss M; Vandivier RW; Kiser TH;
    Pharmacotherapy; 2019 Mar; 39(3):232-241. PubMed ID: 30592541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Norepinephrine Weight-Based Dosing Compared With Non-Weight-Based Dosing in Achieving Time to Goal Mean Arterial Pressure in Obese Patients With Septic Shock.
    Droege CA; Ernst NE
    Ann Pharmacother; 2017 Jul; 51(7):614-616. PubMed ID: 28205455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ketamine/propofol admixture (ketofol) at induction in the critically ill against etomidate (KEEP PACE trial): study protocol for a randomized controlled trial.
    Smischney NJ; Hoskote SS; Gallo de Moraes A; Racedo Africano CJ; Carrera PM; Tedja R; Pannu JK; Hassebroek EC; Reddy DR; Hinds RF; Thakur L
    Trials; 2015 Apr; 16():177. PubMed ID: 25909406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic dosing in obesity: the search for optimum dosing strategies.
    Tucker CE; Lockwood AM; Nguyen NH
    Clin Obes; 2014 Dec; 4(6):287-95. PubMed ID: 25826157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low and Highly Variable Exposure to Prophylactic LMWH Nadroparin in Critically Ill Patients: Back to the Drawing Board for Prophylactic Dosing?
    Diepstraten J; van Rongen A; Zijlstra MP; Kruip MJHA; van der Heiden PLJ; Ter Heine R
    Clin Pharmacokinet; 2023 Feb; 62(2):297-305. PubMed ID: 36581732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoenergetic feeding does not improve outcomes in critically ill patients with premorbid obesity: a post hoc analysis of a randomized controlled trial.
    Charles EJ; Kane WJ; Willcutts KF; O'Donnell KB; Petroze RT; Sawyer RG
    Nutr Res; 2020 Feb; 74():71-77. PubMed ID: 31954847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic changes and dosing modification of aminoglycosides in critically ill obese patients: a literature review.
    Velissaris D; Karamouzos V; Marangos M; Pierrakos C; Karanikolas M
    J Clin Med Res; 2014 Aug; 6(4):227-33. PubMed ID: 24883145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacokinetics of antibiotics in obese and critical care patients].
    Stahlmann R; Lode H
    Dtsch Med Wochenschr; 2015 Feb; 140(4):271-6. PubMed ID: 25704524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unfractionated heparin dosing for venous thromboembolism in morbidly obese patients: case report and review of the literature.
    Myzienski AE; Lutz MF; Smythe MA
    Pharmacotherapy; 2010 Mar; 30(3):324. PubMed ID: 20180615
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.